Rajesh Palviya of Axis Securities sees bullish momentum continuing as Nifty holds above key support. Pharma, oil & gas, and capital goods are showing strong breakouts. Glenmark and Reliance are top picks. Meanwhile, Trent may consolidate between Rs 5,000–Rs 6,000, offering a potential buy on dips opportunity for long-term investors.
Smarten Power System IPO opens on Monday. Check price band, GMP, other details
Smarten Power System’s Rs 50 crore SME IPO opens on July 7, with shares priced at Rs 100 each. The issue includes fresh equity and offer for sale, and will list on NSE SME platform on July 14.
ET Market Watch: Markets up but jittery: What’s spooking investors?
Dreamfolks sees Rs 169-cr stake sale by Bajaj Finance, others via block deal; shares tank 12%
According to exchange data, Bajaj Finance offloaded 3.09 lakh shares at Rs 196.32 apiece, totalling Rs 61 crore. Motilal Oswal Mutual Fund sold 2.7 lakh shares at Rs 211.14, fetching Rs 57.04 crore, while HRTI Private Limited exited 2.61 lakh shares at Rs 196.48, amounting to Rs 51.37 crore.
Sebi may widen Jane Street probe to other indices, exchanges: Report
Sebi Probe: Sebi’s probe into Jane Street may expand beyond Nifty options to include trades on other indices and exchanges. While the investigation could take time, it is unlikely to trigger broad market disruption, an ET Now report stated. Retail F&O participation has eased, but nearly 90% of traders still continue to incur losses.
Expect double-digit earnings growth from BSE 500 companies going ahead: Mukul Kochhar
Investec Capital Services’ Mukul Kochhar highlights India’s strong underlying market strength, anticipating double-digit earnings growth for BSE 500 companies. While responsible fiscal management and lower inflation support valuations, securing trade treaties remains crucial for integrating into global supply chains. Kochhar favors domestic cyclicals, financials, industrials, and auto sectors, while expressing caution towards consumer staples and IT services.
Emcure Pharma shares in focus as Bain Capital likely to offload 2.4% stake via block deal
BC Investments IV, linked to Bain Capital, is expected to sell a 2.4% stake in Emcure Pharmaceuticals. The sale will occur through a block deal valued at Rs 551 crore. About 45.5 lakh shares will be sold at Rs 1,279.80 each. Kotak Securities is managing the deal. Emcure’s stock is currently below its all-time high despite strong quarterly results.
Moderate expectations on market returns; insurance still a relative bet: A Balasubramanian
A Balasubramanian of ABSL AMC highlights the growth potential of India’s insurance sector, particularly life insurance, driven by increased focus and new product offerings. Despite current economic slowdown indicators like reduced credit offtake and GST dips, he remains optimistic. He anticipates market growth due to proactive measures by the Reserve Bank of India and a forward-looking market perspective.
SME multibagger Cool Caps Industries to trade ex-split and ex-bonus on Friday. Your last chance to buy today
Cool Caps Industries will trade ex-split and ex-bonus on July 4, 2025, for its 1:5 stock split and 1:1 bonus shares. This Friday marks the record date, offering investors a final chance to buy shares and qualify for additional shares from the sub-division and bonus issue. The company’s shares have yielded 137% returns over the past year.
Sachin Shah on macro tailwinds that will boost Indian market, 3 sectors to bet on
Indian equity markets showed gains despite geopolitical tensions. Regulator confidence, GDP growth, and RBI support boosted the market. Subdued oil prices and a favorable monsoon outlook fueled optimism. Sachin Shah highlights private sector banking and auto as undervalued sectors. He also sees growth in contract research and manufacturing. Indian companies offer value in textiles, electronics, and engineering.
